This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Bruxism Management Market

Market Insights on Bruxism Management Market covering sales outlook, demand forecast & up-to-date key trends

Bruxism Management Market By Type, Cause & Region - Forecast 2022 - 2032

Bruxism Management Market Snapshot

The global bruxism management market is anticipated to grow at a fast pace by reaching US$ 5.3 Billion in 2022. As per Future Market Insights (FMI), the market is likely to be valued at US$ 10.1 Billion in 2032 and exhibit growth at a CAGR of 6.9% in the forecast period from 2022 to 2032. The rising prevalence of obstructive sleep apnea is set to augment the demand for bruxism management techniques in the near future.

Report Attribute

Details

Bruxism Management Market Estimated Base Year Value (2021)

US$ 4.8 Billion

Bruxism Management Market Expected Market Value (2022)

US$ 5.3 Billion

Bruxism Management Market Anticipated Forecast Value (2032)

US$ 10.1 Billion

Bruxism Management Market Projected Growth Rate (2022-2032)

6.9% CAGR

Bruxism is when a person clenches, grinds, or gnashes their teeth while not chewing. It often occurs during sleep, but it can also happen during waking hours. The person is usually not consciously aware that they are doing it.

Various symptoms of bruxism include broken or loose fillings, a dull headache, facial pain, worn teeth, jaw pain, and similar others. It is a common condition in young children when their teeth are growing.

Another main cause of bruxism in adults is stress. The usage of caffeine and alcohol can also lead to bruxism. In some individuals, it happens if they have a missing tooth or if their bite is not aligned.

Is the Rising Prevalence of Sleep Apnea Pushing Bruxism Management Market Growth

The rising prevalence of neurological disorders, such as Parkinson’s and Huntington’s disease among the geriatric population is a vital factor that is likely to push sales of bruxism management devices in the evaluation period. As per Parkinson’s Foundation, more than 10 million people are currently living with the disease across the globe. This number is estimated to grow at a steady pace, thereby propelling the market.

In addition to that, the growing cases of sleep apnea are expected to contribute to the global market growth. The American Sleep Apnea Association mentions that about 22 million people suffer from sleep apnea every year in the U.S. alone. Out of this, nearly 80% cases of severe and moderate obstructive sleep apnea remain undiagnosed. Spurred by the aforementioned factors, the global market is set to grow at a fast pace.

Customize this Report

Let us know your requirement to get
100% FREE customization

Which Factors May Hamper the Bruxism Management Market Growth

Researchers have found that medications are not very effective for the treatment of bruxism. Thus, they are striving to manage the consequences of this condition by promoting preventative measures. It involves the utilization of occlusal splints, mandibular advancement devices, stress management, and similar other devices.

A wide range of medications and muscle relaxants are being used to treat sleep bruxism. However, these medications can cause numerous side-effects, such as muscle weakness, nausea, and constipation. Also, bruxism mouth guards often ground down with time. The unavailability of effective treatment options may hence hamper the global bruxism management market growth.

Why is Surging Anxiety Affecting the North America Bruxism Management Market

North America is set to dominate in the near future by accounting for the largest bruxism management market share. Rising stress and anxiety among the populaces in the U.S. and Canada is one of the major factors that is expected to bode well for the regional market. 

As per the National Alliance on Mental Illness, more than 40 million adults have an anxiety disorder in the U.S. Likewise, nearly 7% of children belonging to the age group of 3 to 17 years, experience various issues with anxiety every year in the country. This trend is projected to continue throughout the forthcoming years, thereby boosting the regional market.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

How is the Entry of New Players Fueling the Asia Pacific Bruxism Management Market

At present, Asia Pacific has a relatively low penetration for bruxism treatment products. Governments of various countries, such as India, China, South Korea, and Japan are investing huge sums to develop their healthcare infrastructure. Many international companies are expected to set up their manufacturing facilities in these countries owing to the easy availability of low-cost labor and raw materials.

The increasing prevalence of sleeping bruxism across Asia Pacific is another major factor that is set to fuel the growth. The rising workplace stress and rapidly changing lifestyle in this region are also projected to expand the Asia Pacific bruxism management market size.

Market Competition

Some of the renowned companies present in the global bruxism management market are F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Eli Lilly and Company, Mayne Pharma, Cadila Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Pfizer, Endo International plc, Akervall Technologies, Inc., and Mylan N.V. among others.

Majority of the companies operating in the global market are increasingly focusing on research and development activities to introduce cutting-edge bruxism treatment options. The market is projected to witness the entry of several start-up companies that would target the infant population and come up with new medications for them.

In June 2021, for instance, SelfSense Technologies, an Irish start-up firm, announced its plan to close a €1 million funding round by launching its new intelligent mouth guards in Europe and Ireland. The company aims to cater to the needs of patients suffering from bruxism by providing them with innovative guards. Thus, the increasing number of new product launches by start-up companies is set to propel the growth in this market.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Report Scope

Report Attribute

Details

Growth Rate

CAGR of 6.9% from 2022 to 2032

Base Year for Estimation

2021

Historical Data

2015-2020

Forecast Period

2022-2032

Quantitative Units

Revenue in USD Billion, Volume in Kilotons and CAGR from 2022-2032

Report Coverage

Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis

Segments Covered

  • Type
  • Treatment Type
  • Cause
  • Distribution Channel
  • Region

Regions Covered

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • Japan
  • Middle East and Africa

Key Countries Profiled

  • U.S
  • Canada
  • Brazil
  • Argentina
  • Germany
  • U.K
  • France
  • Spain
  • Italy
  • Nordics
  • BENELUX
  • Australia & New Zealand
  • China
  • India
  • ASEAN
  • GCC
  • South Africa

Key Companies Profiled

  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline plc
  • Eli Lilly and Company
  • Mayne Pharma
  • Cadila Pharmaceuticals
  • Teva Pharmaceutical Industries Ltd.
  • Pfizer
  • Endo International plc
  • Akervall Technologies, Inc.
  • Mylan N.V.

Customization

Available Upon Request

Key Segments Profiled in the Bruxism Management Industry Survey

By Type:

  • Diurnal Bruxism
  • Nocturnal Bruxism

By Treatment Type:

  • Drugs
  • Antianxiety Agents
  • Tranquilizers
  • Sedatives
  • Muscle Relaxants
  • Dental Approaches
  • Occlusal Splint
  • Mouth Guard

By Cause:

  • Obstructive Sleep Apnea
  • Sleep Paralysis
  • Malocclusion
  • Gastroesophageal Reflux Disease (GERD)
  • Depression
  • Anxiety
  • Others

By Distribution Channel:

  • Institutional Sales
  • Hospital
  • Dental Clinic
  • Retail Sales
  • Drug Store
  • Retail Store
  • Supermarket
  • Mail Order Pharmacies

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • Japan
  • Middle East and Africa

Frequently Asked Questions

The global bruxism management market is anticipated to reach US$ 10.1 Billion in 2032.

North America is set to lead the bruxism management market in the forecast period.

F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Eli Lilly and Company, Mayne Pharma, Cadila Pharmaceuticals, and Teva Pharmaceutical Industries Ltd. are some of the renowned companies in the bruxism management market.

Table of Content

NA

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

NA

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

NA

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Pain Management Devices Market

Published : February 2022

Healthcare

Infusion Pharmacy Management Market

Published : July 2017

Healthcare

Hospital Capacity Management Solutions Market

Published : February 2022

Healthcare

Obesity Management Market

Published : June 2021

Google translate

Bruxism Management Market